{
  "case_id": "case_0001",
  "provider": "goog",
  "status": "processed",
  "patient_demographics": {
    "age": 20.13,
    "sex": "Female",
    "genderIdentity": "Transgender Female",
    "ancestry": "Middle Eastern / North African"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesions involving:\n- left optic nerve (cranial nerve II) and right C5 spinal cord.",
      "structured_data": {
        "gt_lesions_english": [
          "right C5 myelopathy",
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "Optic Nerve",
            "side": "left",
            "qualifier": null
          },
          {
            "location": "C5-C6 Spinal Cord",
            "side": "right",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left optic nerve (cranial nerve II)",
          "right C5 myelopathy"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 2,
        "correctly_identified_count": 2,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included: Multiple sclerosis\n  \nThese suggested differentials are reasonable:\n\n- Neuromyelitis Optica Spectrum Disorder; MOG Antibody-Associated Disease; Neurosarcoidosis",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Multiple Sclerosis",
          "Neuromyelitis Optica Spectrum Disorder",
          "MOG Antibody-Associated Disease",
          "Neurosarcoidosis"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation",
          "Hay fever": "comorbidity",
          "Hypnogogic jerks": "comorbidity"
        },
        "correctly_mentioned": [
          "Multiple sclerosis"
        ],
        "missing_diagnoses": [
          "Hay fever",
          "Hypnogogic jerks"
        ],
        "additional_diagnoses": [
          "Neuromyelitis Optica Spectrum Disorder",
          "MOG Antibody-Associated Disease",
          "Neurosarcoidosis"
        ]
      },
      "scoring": {
        "ms_included": 1,
        "incidental_total_count": 0,
        "incidental_missing_count": 0,
        "incidental_missing_proportion": null,
        "comorbidity_total_count": 0,
        "comorbidity_missing_count": 0,
        "comorbidity_missing_proportion": null
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\nAgree with all suggestions.\n\n- MRI including the Orbits and Cervical Spine and CSF test for Oligoclonal Bands would potentially inform a diagnosis of multiple sclerosis.",
      "structured_data": {
        "gt_required_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain, orbits, and full spinal cord with gadolinium contrast",
          "Aquaporin-4 (AQP4) antibody serology",
          "Myelin Oligodendrocyte Glycoprotein (MOG) antibody serology",
          "Lumbar puncture for CSF analysis (including cell count, protein, glucose, oligoclonal bands, and IgG index)",
          "Serum for oligoclonal bands (for comparison with CSF)",
          "Visual Evoked Potentials",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "Erythrocyte Sedimentation Rate (ESR)",
          "Antinuclear Antibody (ANA)",
          "Angiotensin-Converting Enzyme (ACE)",
          "Vitamin B12",
          "Syphilis serology",
          "HIV serology"
        ],
        "found_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests": []
      },
      "scoring": {
        "gt_tests_count": 3,
        "found_tests_count": 3,
        "missing_tests_count": 0,
        "proportion_found": 1.0,
        "proportion_missing": 0.0
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- No indication this isn't an exacerbation of an old deficit/pseudorelapse.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "High-Dose Intravenous Methylprednisolone",
            "timing": "Start Now",
            "reasons": [
              "To reduce inflammation of active demyelinating lesions",
              "To shorten the duration and severity of the acute relapse",
              "To accelerate functional recovery"
            ]
          },
          {
            "treatment": "Disease-Modifying Therapy (DMT)",
            "timing": "Delay",
            "reasons": [
              "Awaiting definitive diagnostic confirmation and exclusion of mimics (NMOSD, MOGAD)",
              "To allow for a considered discussion with the patient about long-term treatment options after the acute phase"
            ]
          },
          {
            "treatment": "Multidisciplinary Rehabilitation (Physiotherapy and Occupational Therapy)",
            "timing": "Start Now",
            "reasons": [
              "To address current functional deficits including weakness and sensory ataxia",
              "To improve gait stability and reduce fall risk",
              "To maximize long-term functional recovery"
            ]
          },
          {
            "treatment": "Symptomatic Management for Spasticity",
            "timing": "Delay",
            "reasons": [
              "The degree of residual spasticity after acute relapse treatment is unknown",
              "To avoid unnecessary medication by re-assessing the need once the clinical picture has stabilized"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-Dose Intravenous Methylprednisolone",
            "timing": "Start Now",
            "reasons": [
              "To reduce inflammation of active demyelinating lesions",
              "To shorten the duration and severity of the acute relapse",
              "To accelerate functional recovery"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "No indication this isn't an exacerbation of an old deficit/pseudorelapse.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- No indication this isn't an exacerbation of an old deficit/pseudorelapse.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Disease-Modifying Therapy (DMT)",
            "timing": "Delay",
            "reasons": [
              "Awaiting definitive diagnostic confirmation and exclusion of mimics (NMOSD, MOGAD)",
              "To allow for a considered discussion with the patient about long-term treatment options after the acute phase"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Need a pregnancy test result.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_safety": 1,
          "gt_reasons_count": 2,
          "acknowledged_reasons_count": 0,
          "missed_reasons_count": 2,
          "proportion_reasons_acknowledged": 0.0,
          "proportion_reasons_missed": 1.0
        },
        "dmt": {
          "decision_safety": 0,
          "gt_reasons_count": 3,
          "acknowledged_reasons_count": 1,
          "missed_reasons_count": 2,
          "proportion_reasons_acknowledged": 0.3333333333333333,
          "proportion_reasons_missed": 0.6666666666666666
        }
      }
    }
  }
}